ArQule amends R.W. Johnson deal

ARQL amended a 1998 deal with R.W. Johnson Pharmaceutical, a subsidiary of Johnson & Johnson (JNJ), to discover compounds in various therapeutic areas. Under the original deal, JNJ took out a four-yea...